62 results
8-K
EX-99.1
VERV
Verve Therapeutics Inc
8 May 24
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
7:15am
“forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties
8-K
VERV
Verve Therapeutics Inc
2 Apr 24
Other Events
7:13am
Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties, including statements regarding expectations for the Company’s
8-K
EX-99.1
6e4v6elnp31f1jjqm4fh
27 Feb 24
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
7:45am
8-K
gx6no
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
8-K
EX-99.1
74eqfyl
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
8-K
EX-1.1
v4iigbqxx yv32ov1
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
8-K
jdv5pmb39t
13 Nov 23
Other Events
6:34am
8-K
EX-99.1
pvmj046
7 Nov 23
Verve Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
7:00am
8-K
ausoimhgeufvsp0vje
23 Oct 23
Other Events
6:41am
8-K
EX-99.1
n1wbstjtkavgn5yx3
10 Aug 23
Verve Therapeutics Highlights Recent Company Progress and Reports Second Quarter 2023 Financial Results
7:00am
8-K
av9 jkqj56vyf3kcqbf
15 Jun 23
Entry into a Material Definitive Agreement
6:37am